Skip to content

Cytokinetics CYTK Convertible Notes Noncurrent

Convertible Notes Noncurrent at other companies

Starwood Property Trust logo
Starwood Property TrustSTWD
$1.34B
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO
$710K-84.1%
AST SpaceMobile logo
AST SpaceMobileASTS
$0-100%
Veradermics
 logo
Veradermics MANE
$0-100%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
3
Super Micro Computer, Inc. logo
Super Micro Computer, Inc.SMCI
$21.44M-59.9%

Other financials

Income statement

See full
Revenue$19.4M+1,126%
Operating income-$183.6M-18.0%
Net income-$206.0M-27.7%
EPS (diluted)-$1.67-22.8%

Balance sheet

See full
Cash & equivalents$129.8M+76.2%
Total debt$418.2M+75.8%
Total equity-$826.6M-210%
Total assets$1.3B+0.7%

Cash flow

See full
Operating cash flow-$145.5M-10.5%
CapEx$5.9M+4.7%
Free cash flow-$151.4M-10.3%

Valuation

See full
Market cap$10.7B+70.6%
Enterprise value$10.98B+70.7%
P/S101.1×-225×

Profitability

See full
Operating margin-605.1%-268pp
Net margin-784%-337pp
FCF margin-518.8%-223pp

Returns & leverage

See full
Return on equity-337.6%
Debt / equity2.2×
Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept cytk:ConvertibleNotesNoncurrent.

The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's convertible notes noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytokinetics's convertible notes noncurrent?
Cytokinetics (CYTK) reported convertible notes noncurrent of $870.51M in Q1 2026.
What does convertible notes noncurrent mean?
Long-term debt that can be turned into company stock at a later date.
How do you interpret convertible notes noncurrent?
An increase indicates the company has raised capital via convertible debt, potentially impacting future share dilution.
How does convertible notes noncurrent compare across companies?
Frequently used by biotech and tech firms to fund R&D and clinical trials.